Order Article Reprints

Malebari AM, Wang S, Greene TF, O’Boyle NM, Fayne D, Khan MF, Nathwani SM, Twamley B, McCabe T, Zisterer DM, et al. Correction: Malebari et al. Synthesis and Antiproliferative Evaluation of 3-Chloroazetidin-2-ones with Antimitotic Activity: Heterocyclic Bridged Analogues of Combretastatin A-4. Pharmaceuticals 2021, 14, 1119. Pharmaceuticals. 2025; 18(8):1219. https://doi.org/10.3390/ph18081219

Malebari, Azizah M., Shu Wang, Thomas F. Greene, Niamh M. O’Boyle, Darren Fayne, Mohemmed Faraz Khan, Seema M. Nathwani, Brendan Twamley, Thomas McCabe, Daniela M. Zisterer, and et al. 2025. "Correction: Malebari et al. Synthesis and Antiproliferative Evaluation of 3-Chloroazetidin-2-ones with Antimitotic Activity: Heterocyclic Bridged Analogues of Combretastatin A-4. Pharmaceuticals 2021, 14, 1119" Pharmaceuticals 18, no. 8: 1219. https://doi.org/10.3390/ph18081219

Malebari, A. M., Wang, S., Greene, T. F., O’Boyle, N. M., Fayne, D., Khan, M. F., Nathwani, S. M., Twamley, B., McCabe, T., Zisterer, D. M., & Meegan, M. J. (2025). Correction: Malebari et al. Synthesis and Antiproliferative Evaluation of 3-Chloroazetidin-2-ones with Antimitotic Activity: Heterocyclic Bridged Analogues of Combretastatin A-4. Pharmaceuticals 2021, 14, 1119. Pharmaceuticals, 18(8), 1219. https://doi.org/10.3390/ph18081219